Shares of Amsurg Corp. (NASDAQ:AMSG) saw unusually-high trading volume on Friday . Approximately 1,357,859 shares traded hands during mid-day trading, an increase of 8% from the previous session’s volume of 1,258,325 shares.The stock last traded at $66.84 and had previously closed at $65.40.

AMSG has been the subject of several analyst reports. Bank of America Corp. upgraded Amsurg Corp. from a “neutral” rating to a “buy” rating and set a $104.00 price objective for the company in a report on Thursday, June 16th. Jefferies Group restated a “buy” rating on shares of Amsurg Corp. in a report on Sunday, July 3rd. Citigroup Inc. cut Amsurg Corp. from a “buy” rating to a “neutral” rating in a report on Thursday, June 16th. Wells Fargo & Co. initiated coverage on Amsurg Corp. in a report on Tuesday, June 14th. They set a “market perform” rating for the company. Finally, Cantor Fitzgerald reiterated a “buy” rating and set a $95.00 price target on shares of Amsurg Corp. in a report on Thursday, July 14th. Four analysts have rated the stock with a hold rating and ten have issued a buy rating to the company’s stock. The stock currently has an average rating of “Buy” and a consensus target price of $93.91.

The firm’s 50 day moving average price is $69.92 and its 200-day moving average price is $74.07. The firm has a market capitalization of $3.62 billion and a P/E ratio of 19.97.

Amsurg Corp. (NASDAQ:AMSG) last issued its earnings results on Tuesday, August 2nd. The company reported $1.10 EPS for the quarter, topping analysts’ consensus estimates of $1.08 by $0.02. The business earned $758.50 million during the quarter, compared to analysts’ expectations of $769.88 million. During the same quarter in the previous year, the business earned $0.97 EPS. Amsurg Corp.’s revenue for the quarter was up 21.5% compared to the same quarter last year. Analysts predict that Amsurg Corp. will post $4.33 EPS for the current year.

In other Amsurg Corp. news, insider Robert Jon Coward sold 7,500 shares of the firm’s stock in a transaction on Friday, August 26th. The shares were sold at an average price of $63.65, for a total value of $477,375.00. Following the sale, the insider now owns 97,507 shares of the company’s stock, valued at approximately $6,206,320.55. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink.

An institutional investor recently raised its position in Amsurg Corp. stock. Dimensional Fund Advisors LP raised its stake in Amsurg Corp. (NASDAQ:AMSG) by 3.2% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,994,029 shares of the company’s stock after buying an additional 92,088 shares during the period. Dimensional Fund Advisors LP owned about 6.27% of Amsurg Corp. worth $227,552,000 at the end of the most recent reporting period.

AmSurg Corp. is a surgical center and physician services company. The Company is an owner and operator of ambulatory surgery centers (ASCs) in the United States. The Company is also a provider of outsourced physician services in the areas of anesthesiology, children’s services, emergency medicine and radiology.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.